Haukeland University Hospital
The main objective of this study is establish the performance of miR371 in management of testicular cancer
Testicular Germ Cell Cancer
Seminoma
Non-Seminoma Testicular Cancer
Stage I Testicular Cancer
Stage II Testicular Cancer
Stage III Testicular Cancer
Stage IV Testicular Cancer
Relapse Testicular Cancer
Biomarker analysis
The main objective of the study is to asses the sensitivity and specificity of microRNA-371a-5p (miR371) in detection of viable testicular germ tumour cells. To assess the utility of miR371 at orchiectomy, during treatment and surveillance and in early detection of recurrence.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 350 participants |
| Official Title : | MicroRNA-371 as Markers for Disease Activity and as a Tool to Monitor the Effect of Chemotherapy and Early Detection of Recurrence in Patients With Testicular Germ Cell Tumours |
| Actual Study Start Date : | 2016-12-31 |
| Estimated Primary Completion Date : | 2026-12-31 |
| Estimated Study Completion Date : | 2026-12-31 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years to 70 Years |
| Sexes Eligible for Study: | MALE |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Haukeland University Hospital
Bergen, Norway, 5021
RECRUITING
Haugesund Hospital
Haugesund, Norway, 5528
NOT YET RECRUITING
Oslo University Hospital
Oslo, Norway, 0379
RECRUITING
University Hospital of North Norway
Tromsø, Norway, 9038
NOT YET RECRUITING
Sahlgrenska University Hospital
Gothenburg, Sweden, 41345
RECRUITING
Karolinska University Hospital
Stockholm, Sweden,